Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Gyrodyne Company of America Inc (GYRO)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/30/2025: GYRO (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $0
1 Year Target Price $0
| 0 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -100% | Avg. Invested days 16 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/30/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 18.19M USD | Price to earnings Ratio 45.94 | 1Y Target Price - |
Price to earnings Ratio 45.94 | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.36 | 52 Weeks Range 6.80 - 11.96 | Updated Date 06/29/2025 |
52 Weeks Range 6.80 - 11.96 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.18 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -137.05% | Operating Margin (TTM) -121.3% |
Management Effectiveness
Return on Assets (TTM) - | Return on Equity (TTM) - |
Valuation
Trailing PE 45.94 | Forward PE - | Enterprise Value 12400998 | Price to Sales(TTM) 6.64 |
Enterprise Value 12400998 | Price to Sales(TTM) 6.64 | ||
Enterprise Value to Revenue 2.59 | Enterprise Value to EBITDA -8.07 | Shares Outstanding 2199310 | Shares Floating 662432 |
Shares Outstanding 2199310 | Shares Floating 662432 | ||
Percent Insiders 31.95 | Percent Institutions 36.97 |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Gyrodyne Company of America Inc
Company Overview
History and Background
Gyrodyne Company of America Inc. was founded in 1946. Initially focused on helicopter technology, it later transitioned to real estate operations, primarily healthcare-related facilities.
Core Business Areas
- Real Estate: Gyrodyne owns and manages real estate properties, primarily leased to medical and healthcare-related tenants.
Leadership and Structure
As a smaller company, leadership likely consists of a CEO and a small executive team focusing on property management and leasing. Organizational structure is likely lean and centralized.
Top Products and Market Share
Key Offerings
- Commercial Real Estate Leases: Gyrodyne's primary product is leasing commercial real estate, primarily to medical and healthcare tenants. It's difficult to pinpoint a precise market share without specific regional data, but they operate within the broader healthcare real estate market which is highly fragmented. Competitors are other regional and national commercial real estate firms specializing in healthcare properties. Revenue depends on lease rates and occupancy.
Market Dynamics
Industry Overview
The healthcare real estate market is driven by demographics (aging population), technological advancements in medicine, and increasing demand for healthcare services. It is generally stable but can be affected by economic cycles and regulatory changes.
Positioning
Gyrodyne is positioned as a niche player specializing in healthcare-related real estate. Their competitive advantage lies in local market knowledge and relationships with medical tenants.
Total Addressable Market (TAM)
The TAM for healthcare real estate is substantial, estimated in the hundreds of billions of dollars annually. Gyrodyne's position within this TAM is small but focused, allowing them to cater to a specific segment. Hard to quantify since it's local.
Upturn SWOT Analysis
Strengths
- Specialized focus on healthcare real estate
- Long-term relationships with medical tenants
- Stable income from lease agreements
Weaknesses
- Small size limits scalability
- Concentration risk due to focus on a single sector
- Geographic concentration
Opportunities
- Expansion into new geographic markets
- Development of new healthcare facilities
- Acquisition of other healthcare real estate portfolios
Threats
- Economic downturn impacting healthcare spending
- Changes in healthcare regulations
- Increased competition from larger real estate firms
Competitors and Market Share
Key Competitors
- MPW
- HR
- DOC
Competitive Landscape
Gyrodyne's advantages lie in its niche focus and local market knowledge. Disadvantages stem from its small size compared to larger, diversified REITs. The market share is estimated.
Growth Trajectory and Initiatives
Historical Growth: Historical growth is likely moderate and tied to the growth of the healthcare sector and their ability to maintain high occupancy rates.
Future Projections: Future growth projections are speculative without access to management guidance. Expansion into new markets or strategic acquisitions could drive growth.
Recent Initiatives: Recent initiatives would involve property improvements, lease renewals, and potentially acquiring new properties.
Summary
Gyrodyne is a small, specialized real estate company focused on healthcare properties. Its strengths lie in its niche market and stable income, but its size limits its scalability and increases concentration risk. Future growth depends on expansion and successful property management. Its relatively small and niche position implies lower financial data transparency and makes it subject to regional risks and overall market dynamics.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- SEC Filings
- Industry Reports
- Financial News Sources
- Public Stock Data Aggregators
Disclaimers:
The information provided is for informational purposes only and should not be considered investment advice. Financial data may be limited due to the company's size and reporting practices. Market share data is estimated.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Gyrodyne Company of America Inc
Exchange NASDAQ | Headquaters Saint James, NY, United States | ||
IPO Launch date 1995-08-18 | President, CEO, CFO & Treasurer Mr. Gary Jay Fitlin | ||
Sector Real Estate | Industry Real Estate Services | Full time employees 6 | Website https://www.gyrodyne.com |
Full time employees 6 | Website https://www.gyrodyne.com | ||
Gyrodyne, LLC (the "Company") owns and manages a diversified portfolio of real estate properties comprising office, industrial and service-oriented properties in the New York metropolitan area. The Company owns a 63-acre site approximately 50 miles east of New York City on the north shore of Long Island, which includes industrial and office buildings and undeveloped property, and a medical office park in Cortlandt Manor, New York, both of which are the subject of plans to seek value-enhancing entitlements. The Company's common shares are traded on the NASDAQ Capital Market under the symbol GYRO.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.